Last updated: February 2, 2024
Sponsor: University of Manitoba
Overall Status: Active - Recruiting
Phase
3
Condition
Anesthesia
Treatment
Eutectic mixture of local anesthetics (EMLA; Astra Pharmaceutical Products Inc., Westborough, MA)
Control cream
Clinical Study ID
NCT06242977
HS25862 (H2023:047)
Ages 18-65 Male Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Adult patients undergoing hydrocelectomy, spermatocelectomy, epididymectomy,testicular biopsy, scrotal lesion or cyst excision under local anesthesia alone wereincluded.
Exclusion
Exclusion Criteria:
- Patients were excluded if their procedure was to be performed with sedatives (e.g.,inhaled nitrous oxide gas, oral, or IV sedation) or did not provide consent to berandomized
Study Design
Total Participants: 72
Treatment Group(s): 2
Primary Treatment: Eutectic mixture of local anesthetics (EMLA; Astra Pharmaceutical Products Inc., Westborough, MA)
Phase: 3
Study Start date:
January 25, 2024
Estimated Completion Date:
August 30, 2024
Study Description
Connect with a study center
Men's Health Clinic Manitoba
Winnipeg, Manitoba R3K 1M3
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.